Introduction: The 5-year recurrence risk after ischaemic stroke and transient ischaemic
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …

Background Inflammation driven by pro-inflammatory cytokines is a new therapeutic target in
coronary disease. Few data exist on the association of key upstream cytokines and post …

Background and Purpose—The role of inflammation in intracranial large-artery occlusive
disease is unclear. We sought to investigate the relationship between high-sensitivity C …

Background and Purpose—The role of inflammation in intracranial large-artery occlusive
disease is unclear. We sought to investigate the relationship between high-sensitivity C …

Background and purpose–Although patients with transient ischemic attack (TIA) experience
cardiovascular events frequently, strong clinical predictors of recurrence are lacking. High …

Aims: Residual inflammation risk refers to inflammation that still increases the risk of
cardiovascular disease after the level of low-density lipoprotein cholesterol (LDL-C) reached …

Objectives Inflammatory mediators have an important role in the pathogenesis of stroke.
Increased activity of inflammatory mediators initiates the development of atherosclerosis …

Background and hypothesis Inflammation is implicated in the pathogenesis and outcome of
ischaemic injury. Poststroke inflammation is associated with outcome but it remains unclear …

The onset of cerebral ischaemia triggers a cascade of proinflammatory molecular and
cellular events. Clinical studies suggest that the strength of this acute response is important …

Background and Purpose—Inflammatory markers may be associated with recurrent vascular
events after stroke. We aimed to determine the association between IL-6, C-reactive protein …